ESSA Pharma Future Growth
Future criteria checks 0/6
ESSA Pharma's earnings are forecast to decline at 12.4% per annum while its annual revenue is expected to grow at 78.8% per year. EPS is expected to decline by 11.7% per annum.
Key information
-12.4%
Earnings growth rate
-11.7%
EPS growth rate
Biotechs earnings growth | 24.2% |
Revenue growth rate | 78.8% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 03 Jun 2024 |
Recent future growth updates
No updates
Recent updates
We're Not Very Worried About ESSA Pharma's (NASDAQ:EPIX) Cash Burn Rate
Feb 18ESSA Pharma (NASDAQ:EPIX) Is In A Good Position To Deliver On Growth Plans
Aug 16Estimating The Fair Value Of ESSA Pharma Inc. (NASDAQ:EPIX)
Jan 25We're Hopeful That ESSA Pharma (NASDAQ:EPIX) Will Use Its Cash Wisely
Dec 15ESSA Pharma: Update Including Clinical Collaboration Agreement With Janssen
Feb 02ESSA Pharma and Janssen to test combo treatments in prostate cancer setting
Jan 13ESSA Pharma EPS beats by $0.02
Dec 15Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
9/30/2026 | 4 | -75 | -119 | N/A | 5 |
9/30/2025 | N/A | -53 | -81 | N/A | 5 |
9/30/2024 | N/A | -36 | -40 | N/A | 5 |
3/31/2024 | N/A | -28 | -23 | -23 | N/A |
12/31/2023 | N/A | -26 | -22 | -22 | N/A |
9/30/2023 | N/A | -27 | -20 | -20 | N/A |
6/30/2023 | N/A | -27 | -21 | -21 | N/A |
3/31/2023 | N/A | -29 | -24 | -24 | N/A |
12/31/2022 | N/A | -33 | -27 | -27 | N/A |
9/30/2022 | N/A | -35 | -28 | -28 | N/A |
6/30/2022 | N/A | -37 | -28 | -28 | N/A |
3/31/2022 | N/A | -37 | -28 | -28 | N/A |
12/31/2021 | N/A | -39 | -27 | -27 | N/A |
9/30/2021 | N/A | -37 | -25 | -25 | N/A |
6/30/2021 | N/A | -33 | -22 | -22 | N/A |
3/31/2021 | N/A | -29 | -19 | -19 | N/A |
12/31/2020 | N/A | -25 | -18 | -18 | N/A |
9/30/2020 | N/A | -23 | -17 | -17 | N/A |
6/30/2020 | N/A | -22 | -18 | -18 | N/A |
3/31/2020 | N/A | -21 | -17 | -17 | N/A |
12/31/2019 | N/A | -15 | -14 | -14 | N/A |
9/30/2019 | N/A | -13 | -12 | -12 | N/A |
6/30/2019 | N/A | -12 | -9 | -9 | N/A |
3/31/2019 | N/A | -11 | -10 | -10 | N/A |
12/31/2018 | N/A | -12 | -10 | -10 | N/A |
9/30/2018 | N/A | -12 | -10 | -10 | N/A |
6/30/2018 | N/A | -11 | -11 | -11 | N/A |
3/31/2018 | N/A | -5 | -13 | -13 | N/A |
12/31/2017 | N/A | -8 | N/A | -13 | N/A |
9/30/2017 | N/A | -4 | N/A | -17 | N/A |
6/30/2017 | N/A | -7 | N/A | -18 | N/A |
3/31/2017 | N/A | -14 | N/A | -16 | N/A |
12/31/2016 | N/A | -8 | N/A | -19 | N/A |
9/30/2016 | N/A | -13 | N/A | -15 | N/A |
6/30/2016 | N/A | -8 | N/A | -17 | N/A |
3/31/2016 | N/A | -10 | N/A | -18 | N/A |
12/31/2015 | N/A | -12 | N/A | -14 | N/A |
9/30/2015 | N/A | -10 | N/A | -13 | N/A |
6/30/2015 | N/A | -11 | N/A | -10 | N/A |
3/31/2015 | N/A | -6 | N/A | -5 | N/A |
12/31/2014 | N/A | -3 | N/A | -4 | N/A |
9/30/2014 | N/A | -2 | N/A | -2 | N/A |
6/30/2014 | N/A | -1 | N/A | -1 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: EPIX is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: EPIX is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: EPIX is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: EPIX is forecast to have no revenue next year.
High Growth Revenue: EPIX is forecast to have no revenue next year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if EPIX's Return on Equity is forecast to be high in 3 years time